Invention Grant
- Patent Title: Aptamer for FGF2 and use thereof
-
Application No.: US15128495Application Date: 2015-03-24
-
Publication No.: US09987298B2Publication Date: 2018-06-05
- Inventor: Ling Jin
- Applicant: RIBOMIC INC.
- Applicant Address: JP Tokyo
- Assignee: RIBOMIC INC.
- Current Assignee: RIBOMIC INC.
- Current Assignee Address: JP Tokyo
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2014-060966 20140324
- International Application: PCT/JP2015/058992 WO 20150324
- International Announcement: WO2015/147017 WO 20151001
- Main IPC: A61K31/712
- IPC: A61K31/712 ; C07H21/02 ; C07H21/04

Abstract:
Provided by the present invention are an aptamer having an inhibitory activity on FGF2; a complex containing an aptamer having a binding activity or an inhibitory activity on FGF2, and a functional substance (e.g., affinity substance, labeling substance, enzyme, drug delivery vehicle, or drug and the like); a medicament, diagnostic reagent or labeling agent containing an aptamer having a binding activity or an inhibitory activity on FGF2, or a complex containing said aptamer and a functional substance; and the like.
Public/Granted literature
- US20170157165A1 APTAMER FOR FGF2 AND USE THEREOF Public/Granted day:2017-06-08
Information query